Workflow
technical analysis
icon
搜索文档
Meta: Bull Case Remains Intact After Q1 Earnings
Seeking Alpha· 2025-05-06 06:23
投资风格 - 采用逆向投资策略,偏好高风险且流动性差的期权交易 [1] - 投资组合中股票与看涨期权各占50% [1] - 投资期限通常为3至24个月 [1] 选股标准 - 重点关注因非经常性事件导致近期抛售的股票 [1] - 筛选条件包括内部人士在低价位增持股票 [1] - 主要覆盖美国市场,偶尔涉及新兴市场股票 [1] 分析方法 - 使用基本面分析评估公司财务状况、杠杆水平及行业对比 [1] - 对增持股票的内部人士进行专业背景调查 [1] - 技术分析用于优化买卖点,依赖周线图的多色支撑阻力线 [1] 其他特点 - 强调真实性与简洁性,避免空洞术语或自我标榜 [1]
Elanco Animal Health Sells Xdemvy Royalties To Blackstone in $295 Million Deal
Benzinga· 2025-05-06 04:40
交易公告 - 公司以2.95亿美元现金将Xdemvy(洛替拉纳滴眼液0.25%)在美国市场的分级特许权使用费和商业里程碑付款权出售给黑石生命科学和黑石信贷保险[1] - 交易资金将用于加速债务削减 预计到2025年底净杠杆率将降至调整后EBITDA的3.9-4.3倍[1] - 交易涉及2025年4月至2033年8月期间Xdemvy在美国净销售的分级特许权使用费及特定商业里程碑付款[3] 财务影响 - 通过按比例偿还部分未偿还定期贷款 预计将减少约1000万美元利息支出 但会被出售约1000万美元特许权使用费收入所抵消[2] - 公司保留Xdemvy在美国以外市场的所有特许权使用费权利以及洛替拉纳在眼科解决方案之外的其他人类健康应用权利[4] - 预计2025年第一季度调整后每股收益为0.31美元 销售额为12.1亿美元[4] 产品背景 - 2019年公司将洛替拉纳独家授权给Tarsus制药公司用于探索解决人类健康未满足需求[3] - 2023年Xdemvy成为首个获批用于人类的洛替拉纳产品 也是FDA批准的唯一治疗由蠕形螨引起的人类常见眼睑疾病的药物[3] 市场表现 - 公司股票200日移动平均线为12.34美元 当前价格为9.75美元[6] - 交易日报收9.65美元 下跌1.03% Tarsus制药股票报收48美元 下跌1.35%[7]
Amazon: Too Risky, Even For Me
Seeking Alpha· 2025-05-05 21:51
Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...
Alphabet: On Track To Retest $200s By Year End
Seeking Alpha· 2025-05-01 14:41
Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...
Intel: Unlikely To Rebound This Year
Seeking Alpha· 2025-05-01 07:12
Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...
McDonald's Technicals Show Appetite For More Gains Ahead Of Earnings
Benzinga· 2025-05-01 02:54
McDonald’s Corp MCD will report its first-quarter earnings on Thursday. Wall Street expects $2.66 in EPS and $6.09 billion in revenues as the company reports before market hours.The stock is up 16.11% over the past year, 8.38% year-to-date.Let’s examine the charts for McDonald’s stock and how it currently compares to Wall Street estimates.Read Also: Domino’s Pizza Earnings Miss: 3 ETFs That Could Still Deliver Tasty Returns In 2025MCD Stock Strongly Bullish Ahead Of Q1 EarningsChart created using Benzinga P ...
Eli Lilly Stock Has The Technicals: Will Q1 Earnings Deliver Fundamentals?
Benzinga· 2025-05-01 02:06
Eli Lilly And Co LLY will be reporting its first-quarter earnings on Thursday. Wall Street expects $3.05 in EPS and $12.67 billion in revenues as the company reports before market hours.The stock is up 14.35% over the past year, 14.79% YTD.Let’s examine the charts for Eli Lilly stock and how it currently compares to Wall Street estimates.Read Also: $1000 Invested In This Stock 20 Years Ago Would Be Worth This Much TodayLLY Stock Chart Strongly Bullish Ahead Of Q1 EarningsChart created using Benzinga ProEli ...
SJW Group: Great Total Return Potential And Safety
Seeking Alpha· 2025-04-30 18:01
公司研究理念 - 弗里德里希全球研究公司致力于寻找最安全、表现最佳的公司进行股票投资,关注自由现金流、有效资本配置和持续卓越业绩以识别高质量管理团队 [1] 分析师背景 - 伯恩因子有限责任公司创始人有近40年投资和分析经验,曾是注册会计师(1990 - 2017),2000年成为特许金融分析师持证人,擅长定量和定性分析,在技术分析方面经验丰富,对股市历史有浓厚兴趣,拥有经济学学士和管理信息系统工商管理硕士学位,自1985年以来一直积极参与投资分析,20世纪60年代起开始学习投资,高中时拥有第一支个人股票持仓,师从本杰明·格雷厄姆和沃伦·巴菲特,拥有多领域职业经历,在公共和私营部门均有超20年经验 [2] 分析师披露 - 分析师在提及的任何公司中均无股票、期权或类似衍生品头寸,但可能在未来72小时内通过卖空SJW股票、购买看跌期权或类似衍生品建立有利的空头头寸 [3]
Cross Timbers Royalty Trust Has Become Reasonably Valued (Rating Upgrade)
Seeking Alpha· 2025-04-30 08:18
分析师背景与投资方法 - 分析师为化学工程师 拥有食品技术与经济学硕士学位 同时是门萨会员 [1] - 分析师已出版多本投资与数学相关书籍 包括《股票与债券投资 提前退休计划》和《心算 如何在脑海中完成数学计算》等 [1] - 投资决策主要基于基本面与技术分析 并运用期权作为投资工具 45岁实现财务独立目标 [1] - 日常遵循巴菲特原则 通过阅读财务报表而非娱乐内容获取信息 [1] 持仓披露 - 分析师当前未持有任何提及公司的股票 期权或类似衍生品头寸 [2] - 未来72小时内无计划建立相关头寸 文章内容为独立观点 未获得除Seeking Alpha外的其他报酬 [2] - 分析师与提及公司无任何商业关系 [2] (注:文档3内容均为平台免责声明 根据任务要求不予总结)
Tesla: Early Signs Of A Turnaround, But Fundamentals Are Not Driving It
Seeking Alpha· 2025-04-29 21:08
Small deep value individual investor, with a modest private investment portfolio, split approx. 50%-50% between shares and call options. I have a B.Sc. in aeronautical engineering and over 6 years of experience as an engineering consultant in the aerospace sector. The latter statement is not relevant in any way whatsoever to my investment style, but I thought to add it for self-indulgent purposes. I have a contrarian investment style, highly risky, and often dealing with illiquid options. How illiquid? Well ...